GRCENasdaqPharmaceutical PreparationsFiscal year ends March 31
Grace Therapeutics, Inc.
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.88−0.01 (-0.53%)
Close on Oct 19, 2026
- Market cap
- $32.47M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Aug 11, 2023(first seen in filings) | 1-for-6 reverse | Earlier per-share figures multiplied by 6 |
| Jul 10, 2023 | 1-for-6 reverse | Earlier per-share figures multiplied by 6 |
| Nov 10, 2021(first seen in filings) | 1-for-8 reverse | Earlier per-share figures multiplied by 8 |
| Aug 31, 2021 | 1-for-8 reverse | Earlier per-share figures multiplied by 8 |
| Oct 15, 2015 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |